Poseida Therapeutics, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ANTX
AN2 Therapeutics, Inc. |
$1.38 | $60.55 M | -0.81 | 41 | $0 |
![]() CUE
Cue Biopharma, Inc. |
$1.75 | $71.99 M | -1.38 | 53 | $5.49 M |
![]() CYTK
Cytokinetics, Incorporated |
$49.19 | $6.05 B | -9.78 | 498 | $18.47 M |
![]() DYN
Dyne Therapeutics, Inc. |
$24.57 | $3.03 B | -7.77 | 191 | $0 |
![]() FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
![]() GBIO
Generation Bio Co. |
$1.14 | $216.88 M | -1.28 | 174 | $5.90 M |
![]() GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
![]() INAB
IN8bio, Inc. |
$0.35 | $59.13 M | -1.49 | 18 | $0 |
![]() IPSC
Century Therapeutics, Inc. |
$1.05 | $244.54 M | -1.32 | 152 | $2.24 M |
![]() LTRN
Lantern Pharma Inc. |
$4.19 | $60.03 M | -3.44 | 21 | $0 |
![]() MLYS
Mineralys Therapeutics, Inc. |
$13.05 | $652.38 M | -6.03 | 51 | $0 |
![]() MOLN
Molecular Partners AG |
$5.06 | $135.05 M | -2.03 | 167 | $4.97 M |
![]() PASG
Passage Bio, Inc. |
$0.76 | $73.04 M | -0.77 | 58 | $0 |
![]() PEPG
PepGen Inc. |
$3.68 | $537.15 M | -5.11 | 81 | $0 |
![]() PHVS
Pharvaris N.V. |
$18.06 | $843.31 M | -5.8 | 92 | $0 |
![]() PLRX
Pliant Therapeutics, Inc. |
$13.18 | $672.63 M | -3.9 | 171 | $0 |
![]() RVMD
Revolution Medicines, Inc. |
$43.84 | $6.66 B | -10.51 | 534 | $0 |
![]() RVPH
Reviva Pharmaceuticals Holdings, Inc. |
$1.97 | $42.94 M | -0.91 | 15 | $0 |
![]() STOK
Stoke Therapeutics, Inc. |
$11.02 | $774.50 M | -6.14 | 110 | $8.78 M |